Cita APA

Heidenreich, R., Mehr, K. T., Noth, J., Koch, S., Hong, H., Melber, K., . . . Gnad-Vogt, U. (2015). RNAdjuvant(®), a novel, highly-potent RNA-based adjuvant, combines strong immunostimulatory capacities with a favorable safety profile. J Immunother Cancer.

Chicago Style Citation

Heidenreich, Regina, et al. "RNAdjuvant(®), a Novel, Highly-potent RNA-based Adjuvant, Combines Strong Immunostimulatory Capacities With a Favorable Safety Profile." J Immunother Cancer 2015.

Cita MLA

Heidenreich, Regina, et al. "RNAdjuvant(®), a Novel, Highly-potent RNA-based Adjuvant, Combines Strong Immunostimulatory Capacities With a Favorable Safety Profile." J Immunother Cancer 2015.